SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-039171
Filing Date
2023-11-02
Accepted
2023-11-02 17:10:35
Documents
19
Period of Report
2023-10-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 60398
2 ex4-1.htm EX-4.1 134186
3 ex4-2.htm EX-4.2 116752
4 ex10-1.htm EX-10.1 157611
5 ex10-2.htm EX-10.2 206050
6 ex10-3.htm EX-10.3 25668
7 ex99-1.htm EX-99.1 11532
  Complete submission text file 0001493152-23-039171.txt   1086326

Data Files

Seq Description Document Type Size
8 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bfri-20231030.xsd EX-101.SCH 3967
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bfri-20231030_def.xml EX-101.DEF 26984
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bfri-20231030_lab.xml EX-101.LAB 37210
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bfri-20231030_pre.xml EX-101.PRE 25604
13 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6124
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 231373516
SIC: 2834 Pharmaceutical Preparations